Department of Urology, La Croix Du Sud Hôpital, Quint Fonsegrives, France; Comité De Cancérologie, Association Française d'Urologie, Paris, France.
Department of Public Health, PMSI, Ramsay Santé, Paris, France.
Eur Urol Focus. 2022 Sep;8(5):1169-1175. doi: 10.1016/j.euf.2021.06.005. Epub 2021 Jun 17.
Hospital volume is considered to be a quality measure for outcomes after major oncological surgery. However, countrywide data are lacking for radical prostatectomy (RP).
To assess the impact of hospital volume on postoperative outcomes after RP performed using an open (ORP) versus a minimally invasive surgery (MIS, including pure and robot-assisted RP) approach.
DESIGN, SETTING, AND PARTICIPANTS: Data for patients undergoing RP in France from 2014 to 2019 were extracted from the central database of the national health care system.
Primary endpoints were length of hospital stay (LOS), complications (measured as severity index [SI] scores), and hospital readmission rates at 30 and 90 d.
The median annual hospital volume was 19 RPs (interquartile range 1-40) in the overall cohort. MIS was associated with better outcomes than ORP. Greater hospital volume was correlated with shorter LOS (p < 0.001), high SI scores (SI3: p < 0.001; SI4: p < 0.001), and 30-d (p < 0.001) and 90-d readmission rates (p < 0.001). Incidence rates for SI3 and SI4 scores, and 30-d and 90-d readmission were 12.8 %, 5.8 %, 29.8 %, and 35.4 % in very low-volume centres (<10 annual cases) compared with 8.1 %, 1.9 %, 18.1 %, and 23.9 %, respectively, in other centres (all p < 0.001). Hospital volume was an independent risk factor for all outcomes after taking into account age, lymph node dissection, year of surgery, and surgical approach (ORP vs MIS). The main limitation is the lack of post-RP oncological and functional data.
This nationwide analysis of RP procedures shows a significant correlation between hospital volume and postoperative outcomes irrespective of the surgical approach. Very low case volume (<10 annual procedures per centre) is associated with the highest risk of complications, readmission, and prolonged LOS. Greater hospital volume is directly correlated with shorter LOS even beyond this threshold.
In this study we analysed the French nationwide database for removal of the prostate for prostate cancer. We found that the number of these cases that a hospital carries out per year was associated with outcomes after surgery, with better outcomes for higher annual case numbers.
医院容量被认为是主要肿瘤外科手术后结果的质量指标。然而,在根治性前列腺切除术(RP)方面,缺乏全国范围的数据。
评估使用开放式(ORP)与微创外科手术(MIS,包括纯机器人辅助 RP)方法进行 RP 后医院容量对术后结果的影响。
设计、地点和参与者:从国家卫生保健系统的中央数据库中提取了 2014 年至 2019 年在法国接受 RP 的患者的数据。
主要终点是住院时间(LOS)、并发症(以严重指数 [SI] 评分衡量)以及 30 天和 90 天的再入院率。
总体队列中,医院的中位年手术量为 19 例(四分位距 1-40)。MIS 与 ORP 相比,结果更好。更大的医院容量与较短的 LOS 相关(p < 0.001),高 SI 评分(SI3:p < 0.001;SI4:p < 0.001)以及 30 天(p < 0.001)和 90 天再入院率(p < 0.001)。在极低容量中心(<10 例/年),SI3 和 SI4 评分以及 30 天和 90 天再入院的发生率分别为 12.8%、5.8%、29.8%和 35.4%,而在其他中心(所有 p < 0.001),分别为 8.1%、1.9%、18.1%和 23.9%。考虑到年龄、淋巴结清扫、手术年份和手术方式(ORP 与 MIS)后,医院容量是所有结果的独立危险因素。主要局限性是缺乏 RP 后肿瘤学和功能数据。
这项针对 RP 手术的全国性分析表明,医院容量与术后结果之间存在显著相关性,与手术方式无关。极低的病例量(<每年每中心 10 例)与并发症、再入院和 LOS 延长的风险最高相关。即使超过这个阈值,医院容量的增加也与 LOS 的缩短直接相关。
在这项研究中,我们分析了法国全国性的前列腺癌前列腺切除术数据库。我们发现,医院每年进行的这些病例数量与手术后的结果相关,高年度病例数的结果更好。